++
For further information, see CMDT Part 35-12: Trichomoniasis
++
Copious vaginal discharge in women
Nongonococcal urethritis in men
Motile trichomonads on wet mounts
++
Caused by the protozoan Trichomonas vaginalis
Often asymptomatic
For women with symptomatic disease
Vaginal discharge develops after an incubation period of 5 days to 4 weeks
Vulvovaginal discomfort, pruritus, dysuria, dyspareunia, or abdominal pain may be present
Inflammation of the vaginal walls and cervix with punctate hemorrhages are common
Most men infected with T vaginalis are asymptomatic, but it can be isolated from about 10% of men with nongonococcal urethritis
In men with trichomonal urethritis, the urethral discharge is generally more scanty than with other causes of urethritis
++
Traditionally made by identifying the organism in vaginal or urethral secretions
Examination of wet mounts will show motile organisms
Tests for bacterial vaginosis are often positive
pH > 4.5
Fishy odor after addition of potassium hydroxide
Diagnostic tests include point-of-care antigen tests, nucleic acid probe hybridization tests, and nucleic acid amplification assays, both of which offer improved sensitivity compared to wet mount microscopy and excellent specificity
++
The treatment of choice is tinidazole or metronidazole, each as a 2-g single oral dose
Tinidazole may be better tolerated and active against some resistant parasites
If the large single dose cannot be tolerated, an alternative metronidazole dosage is 500 mg orally twice daily for 1 week
All infected persons should be treated, even if asymptomatic, to prevent subsequent symptomatic disease and limit spread
Treatment failure suggests reinfection
However, metronidazole-resistant organisms have been reported and may be treated with